Onconova Therapeutics (ONTX) Reports Q2 Loss of $1.96/Share

Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($1.96), versus ($4.13) reported last year. Revenue for the quarter came in at $2.25 million, versus $123 thousand reported last year.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Rothschild Redburn Upgrades Apple (AAPL) to Buy
• Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c